chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient immediately felt nauseous, clammy, faint, lightheaded, hot.  Symptoms lasted for about 15 minutes.  EMT came to access patient and she was able to call her husband and he came to pick her up from the store
Vertigo, tendency to stagger to right. Lasted waking hours and overnight one time.  Back to normal in morning.  Not reported to doctor.
broke out in a rash next day p/vax covering trunk, had h/a w/malaise;
Swelling and redness at the injection site 5 x 15 cm - posterior arm ecchymosis - anterior arm.
Within minutes of injection to left thigh, this patient developed redness and hives on left thigh. Patient's doctor assessed the localized reaction, recommended OTC antihistamine and ice to affected area and return to clinic for any worsening symptoms or concerns.
administered Flulaval that was exposed to temperatures below freezing; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unknown number of patients who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   In October 2021, the patient received FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The Nurse reported that somebody in the facility administered Flulaval that was exposed to temperatures below freezing to a possible list of 165 patients.  The reporter consented to follow up.  The Lot number and expiration date was not provided since nurse did not have access to the information. The incident of the temperature excursion was previously reported by co worker. After that, it was verified that some of the vaccines were administered to patients.  The reporter did not know exactly how many patients were involved but there was a list of 165 patients who might have received Flulaval after the excursion.
pt recv vax 930AM & devel red over forehead-trunk & extremities around 11:00;pt went to sleep & when woke up 4PM parents brought back to clinic to be checked;
Rash on the back and side of my neck; Severe chapped lips; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 26Mar2021 at 10:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 03Apr2021, the patient experienced rash on the back and side of his neck and severe chapped lips. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on the back and side of neck and severe chapped lips was recovering at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 4/23/2023 PRESENCE OF INFERIOR VENA CAVA FILTER
A pharmacist reported that a child received an injection of tetanus toxoid adsorbed, purogenated on 01/31/2001. On 02/01/2001, the child developed a fever of 104 deg. F. and a "golf ball size" mass at the injection site. No further info was available at the date of this report.
shot recvd 30JUL93 rash & swelling appeared 1AUG93; erythema multiforme & swelling of hands & face; rx DPH;
Patient shingles in her left eye. Patient went to emergency room and the she was refered to an eye doctor who diagnosed with her shingles. Patient is under treatment and can't see clearly with left eye.
30 minutes later, right arm (not injections site) became hot, skin felt numb to touch. Pulled hair and pinched, could not feel. But went away within an hour. Off and on dizziness and nausea all day that got worse by 6pm. Overnight developed 103.8 fever, body aches, chills, nausea. Subsided by morning with just fatigue the next day.
Intense whiplash like headache Blood on the brain aneurysm popped Stroke . Hospitalized from 09/08/ 2021 to 09/17/2021
Patient's right arm was red and flush above elbow.  Her arm had limited range of motion after the injection.  She did not have redness at the site of injection but was red below until elbow
Pt felt faint.  Appeared pale & diaphoresis.  Evaluation by EMS, given juice & food.  Pt recovered & was instructed to mention SX when receiving future vaccines.
Severe joint pain, fever, rash, horrible headache, and slept for 17 straight hours.
This spontaneous report was received from a Registered Nurse referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On an unknown date, the patients' were vaccinated with an improperly stored dose of VARIVAX (anatomical route of vaccination, lot number and expiration date were not provided). The patients' concomitant medications were not reported. The registered nurse reported, that VARIVAX was stored under a temperature of -14.4 degrees C for 54 minutes. Data logger was involved. The vaccine was not exposed to a previous temperature excursion. Additionally, no adverse events was reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Moderna vaccine   Fever, chills, headache, body aches. Felt absolutely Terrible for 30 hours.
Site was itchy almost immediately and continued to itch over the next 2 days till now. 24 hrs after shot I realized the injection site was warm, had a red ring around it, and had a knot. Was the size of a nickel when I first noticed it. The knot is almost the size of a tennis ball shy of 48 hours later.   I am tired, slight headache. Also had horrible hip/lower back pain 24-36 hours later. Took ibuprofen so I could sleep and settle the pain.
"Janssen COVID-19 Vaccine EUA" Seven minutes after recieving the vaccination I started to feel light headed so I sat on the floor and notified medical personnel.  I then passed out for an unknown amount of time but long enough to urinate on myself.  Medical staff put me on a bed and started taking vitals.  My Blood pressure was low but had a high heart rate.  Medical Personnel called the ER to see if I needed to be transfered but it was reccommended to continue observation.  After an hour or two I was released to go home.  I felt weak for over a week after the vaccination.
At the time of injection my tongue got itchy. I could feel it traveling across my face. I sat inside for 30 minutes and another 30 in the parking lot. Around 7 pm I got flu like symptoms that lasted for 36  hours and a vise like headache that lasted for about 60 hours.  A week later I got hives on both arms  swollen and itchy all over my body.  I felt my throat constricting a bit.  The rash itchiness is still ongoing.
Gestational hypertension developed during third trimester, officially diagnosed on 6/26/2021. Systolic blood pressure ranged from 120s to low 140s. Diastolic blood pressure ranged from 74-94. Blood pressure measurements were taken in office and at home by patient. Twice-weekly NSTs from 7/3/2021 until 7/17/2021 to monitor patient and baby. No medication prescribed for blood pressure. This is patient's third pregnancy; the first resulted in living child, the second ended in miscarriage. Est. due date was August 4, 2021. Patient was brought in for induction on 7/17/2021, and she began Pitocin at 2 a.m. on 7/18/2021. Healthy baby boy born at 3:50 p.m. on 7/18/2021, height 19.75 inches, weight 6 lbs., 13 oz.
Headache, Myalgia, Arthralgia, Fever,  chills, fatigue, injection site pain/arm pain, swelling at injection site, rigors Narrative:  Other Relevant History:
Patient arrived at the pharmacy counter on 07/03/18 and spoke to the pharmacist in charge about possible adverse reaction related to BOOSTRIX vaccine. Her chief complaint was: burning sensation on hands and foot (neuropathy), tingling and numbness sensation on arms / legs and joint pain.
Received 4 month immunizations and immediately developed hives on her thighs, arms and head and rash behind her neck. Spoke with dr and infant given 1/2 tsp. of BENADRYL liquid per his orders. Instructed mother to give infant 1/2 tsp BENADRYL q6 hours per dr prn. Instructed to seek medical attention if respiratory problems occur.
Tested positive for COVID-19; A spontaneous report was received from a pharmacist for a nurse who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a positive COVID test.   The patient's medical history was not provided.  No concomitant medications were reported.  On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Batch # 025J202A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On an unknown date after vaccination, the patient tested positive for COVID-19 through a routine, weekly test.  The patient was reportedly already exposed to COVID-19.  No treatment was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, a positive COVID test, was not resolved.; Reporter's Comments: Based on the natural history of COVID-19, and the established information about the mRNA-1273 vaccine, a causal association between the event of positive COVID test and the product use is assessed as unlikely.
Approximately one hour after receiving the vaccine, patient complained of chills and feeling cold. He called the pharmacy and was instructed to monitor his temperature and seek medical care for high fever or severe symptoms. He was contacted the next morning by the pharmacist and he indicated he did seek medical care at a local urgent care. He reported a peak temperature of 102.6 degrees, chills and muscle aches. Urgent care did several tests including throat swab for strep test, urinalysis and chest X-ray and could not find a conclusive cause for the fever. It was determined the fever and corresponding symptoms were a result of the influenza vaccine administered several hours prior. He was given Tylenol to lower the fever and sent home with instructions to monitor fever and seek medical care with any worsening of symptoms. The following morning he reported his fever had broken overnight and he was feeling much better approximately 16 hours post vaccination.
Administered expired doses; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   It was reported that two providers reported to have administered expired doses by mistake. Vaccine was expired on 09-Nov-2021.  No treatment drugs were reported.
ABOUT 10 HOURS AFTER SHOT RECEIVED I STARTED SHAKING VIGOUROUSLY AND DID NOT STOP FOR ALMOST 2 HOURS.  THEN I DEVELOPED A SLIGHT FEVER - 100-101 - BAD HEADACHE, MUSCLE ACHES, BODY ACHES.  TOOK TYLENOL REGULARLY, FINALLY EXCEDRIN FOR HEADACHE AND ICE PACKS FOR BACK OF NECK AND FOREHEAD.  DIBILATING FOR THE NEXT DAY, THEN FEVER BROKE AND FELT BACK TO NORMAL.
Pt was inadvertently administered an expired dose of covid vaccine.  Pt was fine, did not experience any untoward effects.
This spontaneous report was received from a Physician and refers to an unspecified patient of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapy was not provided. On an unknown date in January 2017 (reported as "26 days" before i.e. less than 4 weeks), the patient received properly stored dose of VARIVAX (dose, route, lot # and anatomical location not reported) for prophylaxis. On 02-FEB-2017, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # M028131 with expiry date 03-JUN-2018) (dose, route and anatomical location not reported) for prophylaxis (Inappropriate schedule of drug administration). Exact time frame and temperature at which the vaccine underwent excursion was unknown. However it was reported that the M-M-R II with lot # M028131 underwent a temperature excursion of 32 degrees Fahrenheit to 35 degrees Fahrenheit for a cumulative time frame of 4 hours and a temperature excursion of 47 degrees Fahrenheit to 77 degrees Fahrenheit for a cumulative time frame of 5 hours on different days since 26-JAN-2017 to 27-MAR-2017. Maximum individual time frame was reported as 60 minutes for each cycle. There was no previous temperature excursion. The call was not because of data logger. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA005436: US-009507513-1705USA005435: US-009507513-1705USA005437: US-009507513-1704USA014447: US-009507513-1705USA005438: US-009507513-1705USA005462: US-009507513-1705USA005463.
I was sick on July 4th weekend and I thought it was a cold. I tested positive for COVID-19 and I took two advil for headache. I kept taking showers because I was dripping in sweat because of the fever. I texted my boss the tell him I tested positive and I was out for the rest of the week. My boss took a report on the 4th. I called my doctor and they prescribed me Paxovid for 5 days. I was sleeping for 20 hours out of the day for the first week. I also had a sore throat.  When I had COVID-19 my vision got better while I was taking Paxovid for a few hours. I had metallic taste and dark stool. I had really weird dream, my ears were popping, and congestion. July 13 is when it moved to my lungs and my voice was really deep and I was coughing up phlegm.
Pt called to state that redness, swelling, hardness at injection site and hot to touch was noted 2 days post vaccination. Continues to be redness and swelling remains 3 days post onset. Redness has been noted to be expanding  toward body rather than down the arm. No major changes since past few days.
Information has been received from a consumer concerning her 18 year old daughter with no medical history or drug allergies who on 26-AUG-2009 was vaccinated with the first dose injection of GARDASIL (lot number not reported). There was no concomitant medication. On approximately 28-AUG-2009 (also reported as about 36 to 48 hours after receiving the vaccination) the patient experienced hives all over her body and started to have joint swelling. The patient took BENADRYL but that did not help, so the patient then saw her physician and was given MEDROL DOSEPAK and cortisone shot and by 01-SEP-2009 the patient had recovered. The consumer reported that the physician stated the patient had an allergic reaction to GARDASIL and she should not get anymore doses. There were no laboratory diagnostic studies performed. No further information is available.
A fever began of 102F on 11/2/2017 with a headache and no other symptoms. The fever continued for the next 4 days with no other accompanying symptoms. On Monday the 11/6 the fever broke and a mild red spotty rash developed all over the trunk, face, and upper extremities.
NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 25-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 26-MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210356547.
Headache; Rapid heartbeat; Body aches; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the second dose bnt162b2 (Pfizer, Lot Number: EP69SS) on 30Mar2021 01:30 PM at the age of 64-year-old as single dose for COVID-19 immunisation in left arm. The patient was not pregnant at the time of event and vaccination. Medical history included anxiety, and was allergy to Septra. Concomitant medications received within 2 weeks of vaccination included duloxetine, calcium, magnesium, vitamin D. The patient had taken the first dose COVID 19 Vaccine (Pfizer, Lot number: EN6206) on 08Mar2021 for COVID-19 immunisation in left arm. The patient was not diagnosed with COVID-19 prior to vaccination, and hasn't been tested for COVID-19 since the vaccination. The patient experienced non-serious events: headache, rapid heartbeat, body aches, dizziness on 30Mar2021 10:00 PM with outcome of not recovered. No treatment received for the events.   No follow-up attempts are possible. No further information is expected.
(1) On-going facial sensation on left side, not quite tingling but some kind of nerve and.or muscle sensation.   (2) ED visit to Mass. Eye and Ear Infirmary for sudden onset PVD - posterior visceous detachment.
Patient developed urticaria multiforme rash on lower extremities spreading from thighs to feet. Lesions are urticaria, red, blanching. The lesions persisted and spread for 5 days.
Hospitalization for COVID pneumonia on dates  6/27/22- 6/28/22.  Treated with supportive treatment.
per nurse practitioner who reported to hlth dept mom stated pt had sustained crying x 3hr;taken to local ER crying subsided;just a little fussy next AM;
Headache, Sedation, RespDepression, CoughWheeze, Nausea Vomiting, Syncope, Chills Lightheadness, Chest tightness Narrative: Received 2nd dose on 2/26/21. Felt weaker later that day. Noted onset of HA, fatigue and chills the next day. Symptoms worsened over the next 2 days, including additional symptoms of nausea, lightheadedness, CP and SOB. Felt feverish x 2 days but did not check temperature. Fatigue and chest tightness and coughing continued x 3 days. Missed work x 1 day. History of COVID infection 11/2020.
At yearly physical this year 7/22/07, Uncle and patient reported that 1 week after her first HPV Vaccine was administered on 7/21/08, she began having periods of shortness of breath, dizziness, hand and feet tingling and palpitations with physical activity and exercise. She had never had this difficulty prior to the HPV  vaccine and had a history of being physically active in dance classes4 d/ week and playing softball. The symptoms finally resolved in January 2009. Patient and Uncle reported these symptoms tome at her yearly physical on 7/22/09.
On February 28, 2021 I felt a painful/tender area behind my left ear.  Went to an Urgent Care and ordered steroids.  On Monday 3/1/21 I started to feel some numbness starting on my left side of my face.  Picked up the steroids and took 2 doses on Tuesday 3/2/21.  Made an appointment with an ENT doctor Tuesday 3/2/21 evening, as the numbness and paralysis mostly on left side of face increased significantly.  He believes it's Bell's Palsy. He ordered me stronger steroids and an antiviral which I started the same evening, in addition to labs. Symptoms somewhat improved today 3/3/21.  I once had Bell's Palsy 15 years or so ago, origin unknown.
Swelling under left arm (arm pit and surrounding tissue); aching pain, mild to moderate, worsening with pressure
Swelling and fluid build up in vaccinated arm lasting several days, redness, itching evaluated by MD as possible allergy.
Loud tinnitus began in both ears shortly after getting the 2nd dose of Moderna COVID?19 Vaccine EUA. It is now 48 hours after the injection, and all side-effects have resolved except for the tinnitus, which is still ringing loudly. It is impossible to ignore.
Fever; chills; body aches; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (chills), MYALGIA (body aches) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had history of covid-19 six month back was noted.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (chills), MYALGIA (body aches) and HEADACHE (headache). At the time of the report, PYREXIA (Fever), CHILLS (chills), MYALGIA (body aches) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Body temperature increased: 102 (High) fever, 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided.
1130:  Patient complained of slight headache (8 out of 10) at end of 15 minute observation.  Also notes slight chills, joint pain in left arm and slight dizziness.  States she did eat this AM.DENIES:  Trouble swallowing, chest discomfort or shortness of breath. VITALS: P 60, BP 138/99 (regular cuff, left arm), pulse Ox 100% room air. 1140:  Patient states headache worsening.  Dizziness about the same.  Breathing unaffected.  VITALS: BP 143/89 (large cuff, left arm). Lights dimmed, patient assisted to sitting position on exam table with back support. 1155: Dr. assessed patient with no concerns.  Advised ongoing monitoring for 15 minutes. 1205:  BP 122/83 (large cuff, left arm), P 56  Patient still c/o headache and dizziness is only a little better.  Patient declined wheelchair out of building but agreed to this RN calling to check on her in 1-2 hours.  She feels comfortable driving the short distance home.  Second vaccine scheduled with number provided in case she decides against receiving 2nd shot.